haloperidol has been researched along with fla 797 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bengtsson, S; de Paulis, T; Hall, H; Högberg, T; Johansson, L; Ogren, SO; Ström, P | 1 |
| Angeby-Möller, K; de Paulis, T; Florvall, L; Hall, H; Johansson, L; Kumar, Y; Ogren, SO; Rämsby, S | 1 |
| Amici, L; Baldessarini, RJ; Baldwin, RM; Fu, X; Innis, RB; Kula, NS; Tamagnan, GD | 1 |
| Andersson, I; Gustafsson, K; Westlind-Danielsson, A | 1 |
| Lundström, J; Nilsson, LB; Ogren, SO | 1 |
| Lundström, J; Nilsson, LB; Ogren, SO; Widman, M | 1 |
6 other study(ies) available for haloperidol and fla 797
| Article | Year |
|---|---|
Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Chemical Phenomena; Chemistry; Dopamine Antagonists; Male; Raclopride; Rats; Rats, Inbred Strains; Salicylamides; Spiperone; Structure-Activity Relationship | 1990 |
Potential neuroleptic agents. 3. Chemistry and antidopaminergic properties of substituted 6-methoxysalicylamides.
Topics: Animals; Apomorphine; Benzamides; Chemical Phenomena; Chemistry; Corpus Striatum; Dopamine Antagonists; Humans; Hyperkinesis; Magnetic Resonance Spectroscopy; Male; Rats; Rats, Inbred Strains; Salicylamides; Spiperone; Stereotyped Behavior; Structure-Activity Relationship | 1985 |
Synthesis and affinity of a possible byproduct of electrophilic radiolabeling of [123I]IBZM.
Topics: Benzamides; Indicators and Reagents; Iodine Radioisotopes; Isotope Labeling; Molecular Structure; Pyrrolidines; Structure-Activity Relationship | 2003 |
Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Calcium; Colforsin; Corpus Striatum; Cyclic AMP; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; In Vitro Techniques; Male; Pergolide; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Remoxipride; Salicylamides; Structure-Activity Relationship; Sulpiride | 1994 |
Concentrations of remoxipride and its phenolic metabolites in rat brain and plasma. Relationship to extrapyramidal side effects and atypical antipsychotic profile.
Topics: Animals; Basal Ganglia Diseases; Brain; Catalepsy; Chromatography, High Pressure Liquid; Circadian Rhythm; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Male; Rats; Rats, Sprague-Dawley; Remoxipride; Salicylamides; Spectrophotometry, Ultraviolet | 1993 |
Dopamine D2 blocking activity and plasma concentrations of remoxipride and its main metabolites in the rat.
Topics: Animals; Body Temperature; Chromatography, High Pressure Liquid; Dopamine D2 Receptor Antagonists; Ergolines; Haloperidol; Hypothermia; Male; Pergolide; Quinpirole; Rats; Rats, Sprague-Dawley; Remoxipride; Salicylamides | 1993 |